Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Pais · SciRah

Researcher profile · Semantic Scholar

R. Pais

Share profile

R. Pais — researcher profile on SciRah

h-index: 26
Works: 111
Citations: 3,838

Most-cited papers

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver.
R. Pais, F. Charlotte, L. Fedchuk, P. Bedossa +3 more
2013Journal of Hepatology483 citations
Semantic Scholar
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease
L. Fedchuk, F. Nascimbeni, R. Pais, F. Charlotte +2 more
2014Alimentary Pharmacology and Therapeutics442 citations Open access
Semantic Scholar
NAFLD and liver transplantation: Current burden and expected challenges
R. Pais, A. Barritt, Y. Calmus, O. Scatton +5 more
2016Journal of Hepatology405 citations Open access
Semantic Scholar
From NAFLD in clinical practice to answers from guidelines.
F. Nascimbeni, R. Pais, S. Bellentani, C. Day +3 more
2013Journal of Hepatology349 citations Open access
Semantic Scholar
Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard.
T. Poynard, M. Munteanu, E. Luckina, H. Perazzo +9 more
2013Journal of Hepatology174 citations
Semantic Scholar
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Yasaman Vali, Jenny A. Lee, J. Boursier, S. Petta +33 more
2023The Lancet Gastroenterology and Hepatology158 citations Open access
Semantic Scholar
Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis.
J. Ampuero, R. Pais, R. Aller, R. Gallego-Durán +34 more
2019Clinical Gastroenterology and Hepatology151 citations Open access
Semantic Scholar
Temporal trends, clinical patterns and outcomes of NAFLD‐related HCC in patients undergoing liver resection over a 20‐year period
R. Pais, L. Fartoux, C. Goumard, O. Scatton +3 more
2017Alimentary Pharmacology and Therapeutics120 citations Open access
Semantic Scholar
Fatty liver is an independent predictor of early carotid atherosclerosis.
R. Pais, P. Giral, J. Khan, D. Rosenbaum +3 more
2016Journal of Hepatology111 citations
Semantic Scholar
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
F. Nascimbeni, J. Aron-Wisnewsky, R. Pais, J. Tordjman +6 more
2016BMJ Open Gastroenterology109 citations Open access
Semantic Scholar
Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease.
R. Pais, A. Pascale, L. Fedchuck, F. Charlotte +2 more
2011Clinics And Research in Hepatology and Gastroenterology84 citations
Semantic Scholar
Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery
R. Pais, J. Aron-Wisnewsky, P. Bedossa, M. Ponnaiah +7 more
2022Hepatology83 citations
Semantic Scholar
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
F. Nascimbeni, P. Bedossa, L. Fedchuk, R. Pais +4 more
2019Journal of Hepatology76 citations Open access
Semantic Scholar
An overview of nonalcoholic steatohepatitis: past, present and future directions.
A. Pascale, R. Pais, V. Ratziu
2010Journal of Gastrointestinal and Liver Diseases74 citations
Semantic Scholar
Relationship Among Fatty Liver, Specific and Multiple‐Site Atherosclerosis, and 10‐Year Framingham Score
R. Pais, A. Redheuil, P. Cluzel, V. Ratziu +1 more
2019Hepatology60 citations
Semantic Scholar
Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
R. Pais, E. Rusu, D. Zilișteanu, A. Cîrciumaru +4 more
2015European journal of internal medicine59 citations
Semantic Scholar
Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
Vittoria Zambon Azevedo, C. Silaghi, Thomas Maurel, H. Silaghi +2 more
2022Frontiers in Nutrition51 citations Open access
Semantic Scholar
Do antioxidants prevent colorectal cancer? A meta-analysis.
R. Pais, D. Dumitrascu
2013Romanian journal of internal medicine = Revue roumaine de medecine interne42 citations
Semantic Scholar
Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease
M. Munteanu, R. Pais, V. Peta, O. Deckmyn +13 more
2018Alimentary Pharmacology and Therapeutics41 citations Open access
Semantic Scholar
Age, abdominal obesity, and glycated hemoglobin are associated with carotid atherosclerosis in type 2 diabetes patients with nonalcoholic fatty liver disease.
C. Silaghi, H. Silaghi, A. Craciun, A. Farcaș +5 more
2015Medical ultrasonography38 citations Open access
Semantic Scholar
The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease.
R. Pais, E. Rusu, V. Ratziu
2014Clinical Liver Disease34 citations
Semantic Scholar
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study
Jenny A. Lee, Max Westphal, Yasman Vali, J. Boursier +37 more
2023Hepatology32 citations Open access
Semantic Scholar
Natural History of NAFLD
R. Pais, Thomas Maurel
2021Journal of Clinical Medicine32 citations Open access
Semantic Scholar
Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population
C. Silaghi, H. Silaghi, H. Colosi, A. Craciun +5 more
2016Clujul Medical28 citations Open access
Semantic Scholar
Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
R. Pais, P. Lebray, G. Rousseau, F. Charlotte +11 more
2015Clinical Gastroenterology and Hepatology27 citations Open access
Semantic Scholar
Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction?
A. Silaghi, L. Poantă, A. Valea, R. Pais +1 more
2011Medical ultrasonography24 citations
Semantic Scholar
Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
M. Mallet, C. Silaghi, P. Sultanik, F. Conti +4 more
2023Hepatology23 citations
Semantic Scholar
Accuracy of quantitative ultrasound parameters in the diagnosis of osteoporosis
R. Pais, R. Câmpean, S. Simon, Călin R. Boloşiu +2 more
201023 citations Open access
Semantic Scholar
[Epidemiology and natural history of nonalcoholic fatty liver disease].
R. Pais, V. Ratziu
2012La Revue du praticien22 citations
Semantic Scholar
NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF NON-ALCOHOLIC FATTY LIVER DISEASE.
J. Boursier, M. Guillaume, C. Bouzbib, Adrien Lannes +7 more
2021Clinics And Research in Hepatology and Gastroenterology19 citations Open access
Semantic Scholar
The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis
T. Poynard, V. Peta, M. Munteanu, F. Charlotte +9 more
2018European Journal of Gastroenterology and Hepathology19 citations Open access
Semantic Scholar
Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference
T. Poynard, M. Munteanu, F. Charlotte, H. Perazzo +7 more
2018European Journal of Gastroenterology and Hepathology18 citations Open access
Semantic Scholar
Impact of steatosis and inflammation definitions on the performance of NASH tests
T. Poynard, M. Munteanu, F. Charlotte, H. Perazzo +5 more
2017European Journal of Gastroenterology and Hepathology18 citations Open access
Semantic Scholar
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
O. Deckmyn, T. Poynard, P. Bedossa, V. Paradis +8 more
2022Biomedicines15 citations Open access
Semantic Scholar
LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
T. Poynard, V. Peta, O. Deckmyn, M. Munteanu +21 more
2018Alimentary Pharmacology and Therapeutics14 citations Open access
Semantic Scholar
Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".
H. Perazzo, R. Pais, M. Munteanu, Y. Ngo +9 more
2014Clinics And Research in Hepatology and Gastroenterology14 citations
Semantic Scholar
Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature.
R. Pais, M. Lupşor, L. Poantă, A. Silaghi +3 more
2009Romanian journal of internal medicine = Revue roumaine de medecine interne14 citations
Semantic Scholar
A proposal from the Liver Forum for the management of comorbidities in nonalcoholic steatohepatitis therapeutic trials.
R. Pais, B. Cariou, M. Noureddin, S. Francque +8 more
2023Journal of Hepatology13 citations Open access
Semantic Scholar
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis.
A. Sanyal, A. Nakajima, E. Bugianesi, G. Sebastiani +28 more
2025Clinical Gastroenterology and Hepatology11 citations Open access
Semantic Scholar
Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort
V. Ratziu, R. Surabattula, E. Bugianesi, J. Schattenberg +8 more
2025Gut11 citations Open access
Semantic Scholar
Metabolic and hepatic phenotypes in sarcopenic obesity and impact of bariatric surgery.
Vittoria Zambon Azevedo, Pierre Bel Lassen, J. Aron-Wisnewsky, Laurent Genser +7 more
2024Clinical Nutrition10 citations Open access
Semantic Scholar
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes
T. Poynard, V. Peta, O. Deckmyn, R. Pais +12 more
2019European Journal of Gastroenterology and Hepathology10 citations Open access
Semantic Scholar
Further delineation of fibrosis progression in NAFLD: evidence from a large cohort of patients with sequential biopsies
S. McPherson, R. Pais, L. N. Valenti, J. Schattenberg +8 more
201710 citations Open access
Semantic Scholar
Paraneoplastic hypertrophic osteoarthropathy: evaluation at 25 years after pneumectomy.
L. Poantă, I. Parasca, Elisabeta Fazakas, M. Porojan +2 more
2009Polskie Archiwum Medycyny Wewnetrznej10 citations
Semantic Scholar
Management of patients with type 2 diabetes and MASLD: an overview and joint statement.
Y. Chouik, C. Canivet, J. Julla, T. Mouillot +19 more
2025Diabetes & Metabolism9 citations Open access
Semantic Scholar
Glitazones for human nonalcoholic steatohepatitis
R. Pais, I. Moraru, V. Ratziu
2011Therapeutic Advances in Gastroenterology8 citations Open access
Semantic Scholar
Epicardial adipose tissue and relationship with coronary artery disease
A. Silaghi, R. Pais, A. Valea, A. Mironiuc +1 more
20118 citations Open access
Semantic Scholar
Review article: The need for more efficient and patient‐oriented drug development pathways in NASH—setting the scene for platform trials
J. Pericàs, N. Di Prospero, Q. Anstee, Peter Mesenbrinck +9 more
2023Alimentary Pharmacology and Therapeutics7 citations Open access
Semantic Scholar
Fatty liver and renal function impairment - Time for awareness?
R. Pais, O. Bourron
2017Journal of Hepatology7 citations
Semantic Scholar
Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia
T. Poynard, O. Deckmyn, V. Peta, Mehdi Sakka +7 more
2023Hepatology Communications5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Ratziu×35
Invite
V. Ratziu — researcher profile on SciRah
T. Poynard×18
Invite
T. Poynard — researcher profile on SciRah
F. Charlotte×13
Invite
F. Charlotte — researcher profile on SciRah
D. Thabut×10
Invite
D. Thabut — researcher profile on SciRah

×9

Invite

P. Lebray — researcher profile on SciRah

Invite

M. Munteanu — researcher profile on SciRah

Invite

Y. Ngo — researcher profile on SciRah

Invite

O. Deckmyn — researcher profile on SciRah

Invite

P. Bedossa — researcher profile on SciRah

Invite

V. Peta — researcher profile on SciRah

Invite

C. Housset — researcher profile on SciRah

Invite

H. Perazzo — researcher profile on SciRah